Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04457362 · ClinicalTrials.gov registry record · NA
Wrist Arthroscopy Study
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT04457362 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 20 participants.
The verdict
NCT04457362, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the diagnostic efficacy of Arthrex NanoScope compared to conventional arthroscopic instruments. Patients with wrist pathology who are indicated for an arthroscopic procedure will be enrolled pre-operatively after a thorough discussion of the study aims, risks, and benefits. At the time of surgery, under standard conditions, using standard wrist arthroscopy portals, a diagnostic arthroscopy will be performed with the Arthrex Nanoscope. The diagnostic arthroscopy will be performed in a stepwise manner for consistency with notation of pathology and intended intervention. The diagnostic arthroscopy will then be performed with the standard arthroscopic equipment, again noting pathology and final intervention. Post-operatively, diagnostic accuracy, incidence of change in intervention, and surgeon rated ease of use and confidence will be determined.
Interventions
- DIAGNOSTIC_TEST Diagnostic Arthroscopy using the Arthrex NanoScope
- DIAGNOSTIC_TEST Diagnostic Arthroscopy using standard arthroscopic instruments
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2020-10-10 |
| Est. Completion | 2023-03-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04457362
The ClinicalTrials.gov registry entry for NCT04457362 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Diagnostic Arthroscopy using the Arthrex NanoScope is the first listed.
NCT04457362 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04457362 about?
NCT04457362 is a clinical study titled "Wrist Arthroscopy Study". The purpose of this study is to evaluate the diagnostic efficacy of Arthrex NanoScope compared to conventional arthroscopic instruments. Patients with wrist pathology who are indicated for an arthroscopic procedure will be enrolled pre-operatively after a thorough discussion of the study aims, risks...
What is the current status of trial NCT04457362?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2020-10-10. Estimated completion is 2023-03-22.
What interventions are being tested in trial NCT04457362?
The interventions under investigation include: Diagnostic Arthroscopy using the Arthrex NanoScope (DIAGNOSTIC_TEST), Diagnostic Arthroscopy using standard arthroscopic instruments (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04457362?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.